>
Polarean Imaging logo

POLX - Polarean Imaging Share Price

88.5p 0.5  0.6%

Last Trade - 04/08/21

Sector
Healthcare
Size
Small Cap
Market Cap £184.0m
Enterprise Value £179.6m
Revenue £760k
Position in Universe 864th / 1799
Bullish
Bearish
Unlock POLX Revenue
Momentum
Relative Strength (%)
1m -6.62%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.90 0.88 1.24 2.44 2.30 1.06 2.50 11.3 +3.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, PolareanImaging PLC revenues decreased 54% to $1.1M. Net lossincreased 7% to $6.5M. Revenues reflect Polarisers segmentdecrease of 61% to $536K, Grants segment decrease of 60% to$300K, Canada segment decrease of 90% to $86K, UnitedStates of America segment decrease of 32% to $937K. Highernet loss reflects Selling and distribution expensesincrease from $325K to $918K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for POLX
Graphical History

Revenue

POLX Revenue Unlock POLX Revenue

Net Income

POLX Net Income Unlock POLX Revenue

Normalised EPS

POLX Normalised EPS Unlock POLX Revenue

PE Ratio Range

POLX PE Ratio Range Unlock POLX Revenue

Dividend Yield Range

POLX Dividend Yield Range Unlock POLX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
POLX EPS Forecasts Unlock POLX Revenue
Profile Summary

Polarean Imaging Plc is a medical drug-devising company. The Company with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The Company focuses on improving the level of pulmonary functional imaging, and specializing the use of polarised Xenon gas (129Xe) as an imaging agent to visualize ventilation, and gas exchange. The Group also develops and manufactures high performance MRI radiofrequency (RF) coils which are a required for imaging 129Xe in the MRI system. The United States food and drug administration (FDA) has accepted the group’s III clinical trial and design.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated October 24, 2016
Public Since March 29, 2018
No. of Shareholders: n/a
No. of Employees: 21
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 209,073,166
Free Float (0.0%)
Eligible for
ISAs
SIPPs
POLX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for POLX
Upcoming Events for POLX
Frequently Asked Questions for Polarean Imaging
What is the Polarean Imaging share price?

As of 04/08/21, shares in Polarean Imaging are trading at 88.5p, giving the company a market capitalisation of £184.0m. This share price information is delayed by 15 minutes.

How has the Polarean Imaging share price performed this year?

Shares in Polarean Imaging are currently trading at 88.5p and the price has moved by 0.163k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Polarean Imaging price has moved by 0.117k% over the past year.

What are the analyst and broker recommendations for Polarean Imaging?

Of the analysts with advisory recommendations for Polarean Imaging, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Polarean Imaging is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Polarean Imaging next release its financial results?

Polarean Imaging is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Polarean Imaging dividend yield?

Polarean Imaging does not currently pay a dividend.

Does Polarean Imaging pay a dividend?

Polarean Imaging does not currently pay a dividend.

When does Polarean Imaging next pay dividends?

Polarean Imaging does not currently pay a dividend.

How do I buy Polarean Imaging shares?

To buy shares in Polarean Imaging you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Polarean Imaging?

Shares in Polarean Imaging are currently trading at 88.5p, giving the company a market capitalisation of £184.0m.

Where are Polarean Imaging shares listed? Where are Polarean Imaging shares listed?

Here are the trading details for Polarean Imaging:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: POLX
What kind of share is Polarean Imaging?

Based on an overall assessment of its quality, value and momentum, Polarean Imaging is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Polarean Imaging share price forecast 2021?

Shares in Polarean Imaging are currently priced at 88.5p. At that level they are trading at 14.45% discount to the analyst consensus target price of 103.45.

Analysts covering Polarean Imaging currently have a consensus Earnings Per Share (EPS) forecast of -0.0900875844 for the next financial year.

How can I tell whether the Polarean Imaging share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Polarean Imaging. Over the past six months, the relative strength of its shares against the market has been 7.35%. At the current price of 88.5p, shares in Polarean Imaging are trading at 13.78% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Polarean Imaging PE Ratio?

We were not able to find PE ratio data for Polarean Imaging.

Who are the key directors of Polarean Imaging?

Polarean Imaging's management team is headed by:

Richard Hullihen - CEO
Kenneth West - COO
Bastiaan Driehuys - CTO
Juergen Laucht - NED
Jonathan Allis - CHM
Kiarash Emami - VPR
Charles Osborne - CFO
Cyrille Petit - NED
Stephen Austin - SEC
Who are the major shareholders of Polarean Imaging?

Here are the top five shareholders of Polarean Imaging based on the size of their shareholding:

Amati Global Investors Limited Investment Advisor
Percentage owned: 12.49% (26.1m shares)
Bracco Imaging Spa Corporation
Percentage owned: 7.84% (16.4m shares)
Driehuys (Bastiaan) Individual Investor
Percentage owned: 5.87% (12.3m shares)
NUKEM Isotopes Imaging GmbH Corporation
Percentage owned: 5.37% (11.2m shares)
MI Chelverton UK Equity Growth Fund Mutual Fund
Percentage owned: 4.65% (9.73m shares)
Similar to POLX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.